Table 1 Description of the patient population and PLK-1 expression.
From: The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
Characteristic | Patients (n = 36) |
|---|---|
Age (Median ± SD) | 43.2 ± 15.7 |
Histology | Â |
   Undifferentiated | 21 (58.3%) |
   Differentiated | 15 (41.7%) |
Primary tumor stages | Â |
   T(1) | 6 (16.7%) |
   T(2) | 7 (19.5%) |
   T(3) | 9 (25%) |
   T(4) | 14 (38.8%) |
Nodular metastasis | Â |
   Yes | 6 (16.7%) |
   No | 30 (83.3%) |
Distant metastasis | Â |
   Yes | 3 (8.3%) |
   No | 33 (91.7%) |
PLK-1 expression | Â |
   High (score 3) | 17 (47.2%) |
   Middle (score 2) | 8 (22.2%) |
   Low (score 1) | 7 (19.5%) |
   Negative(score 0) | 4 (11.1%) |